Piergiorgio Giannessi

506 total citations
11 papers, 221 citations indexed

About

Piergiorgio Giannessi is a scholar working on Oncology, Cancer Research and Dermatology. According to data from OpenAlex, Piergiorgio Giannessi has authored 11 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Cancer Research and 3 papers in Dermatology. Recurrent topics in Piergiorgio Giannessi's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (4 papers) and Cancer-related Molecular Pathways (3 papers). Piergiorgio Giannessi is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (4 papers) and Cancer-related Molecular Pathways (3 papers). Piergiorgio Giannessi collaborates with scholars based in Italy and United Kingdom. Piergiorgio Giannessi's co-authors include Pierfranco Conté, Editta Baldini, G. Gardin, Tiziana Prochilo, Paolo Bruzzi, Paola Collecchi, Giuseppe Evangelista, R. Rosso, Manuela Roncella and F Carnino and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of the New York Academy of Sciences.

In The Last Decade

Piergiorgio Giannessi

11 papers receiving 217 citations

Peers

Piergiorgio Giannessi
Arun Nagarajan United States
Jasmine Sukumar United States
Anca Mera United Kingdom
G Moro Italy
Kelly Marcom United States
Piergiorgio Giannessi
Citations per year, relative to Piergiorgio Giannessi Piergiorgio Giannessi (= 1×) peers Andrea Stefek

Countries citing papers authored by Piergiorgio Giannessi

Since Specialization
Citations

This map shows the geographic impact of Piergiorgio Giannessi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piergiorgio Giannessi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piergiorgio Giannessi more than expected).

Fields of papers citing papers by Piergiorgio Giannessi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piergiorgio Giannessi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piergiorgio Giannessi. The network helps show where Piergiorgio Giannessi may publish in the future.

Co-authorship network of co-authors of Piergiorgio Giannessi

This figure shows the co-authorship network connecting the top 25 collaborators of Piergiorgio Giannessi. A scholar is included among the top collaborators of Piergiorgio Giannessi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piergiorgio Giannessi. Piergiorgio Giannessi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Giannessi, Piergiorgio, et al.. (2005). Gemcitabine in combination with capecitabine in metastatic breast carcinoma: A phase I-II study. Journal of Clinical Oncology. 23(16_suppl). 870–870. 4 indexed citations
2.
Baldini, Editta, Tiziana Prochilo, B. Salvadori, et al.. (2004). Multicenter randomized phase III trial of Epirubicin plus Paclitaxel vs Epirubicin followed by Paclitaxel in metastatic breast cancer patients: focus on cardiac safety. British Journal of Cancer. 91(1). 45–49. 24 indexed citations
3.
Conté, Pierfranco, Valentina Guarneri, Paolo Bruzzi, et al.. (2004). Concomitant versus sequential administration of epirubicin and paclitaxel as first‐line therapy in metastatic breast carcinoma. Cancer. 101(4). 704–712. 50 indexed citations
4.
Baldini, Editta, G. Gardin, Piergiorgio Giannessi, et al.. (2003). Accelerated versus standard cyclophosphamide, epirubicin and5-fluorouracil or cyclophosphamide, methotrexate and5-fluorouracil: a randomized phase III trial in locally advanced breast cancer. Annals of Oncology. 14(2). 227–232. 49 indexed citations
5.
Collecchi, Paola, Editta Baldini, Piergiorgio Giannessi, et al.. (1998). Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers. European Journal of Cancer. 34(11). 1701–1704. 41 indexed citations
6.
Baldini, Editta, Carmelo Tibaldi, Monica Lencioni, et al.. (1997). Filgrastim and Lack of Support of Intensive Adjuvant Chemotherapy for High-Risk Breast Cancer Patients. American Journal of Clinical Oncology. 20(2). 169–172. 3 indexed citations
7.
Baldini, Editta, G. Gardin, Piergiorgio Giannessi, et al.. (1997). A Randomized Trial of Chemotherapy with or without Estrogenic Recruitment in Locally Advanced Breast Cancer. Tumori Journal. 83(5). 829–833. 7 indexed citations
8.
Michelotti, Andrea, Antonella Romanini, Piergiorgio Giannessi, Carmelo Bengala, & Pierfranco Conté. (1996). Accelerated Epirubicin-Ifosfamide-Dacarbazine Regimen in Patients with Adult Soft Tissue Sarcomas. American Journal of Clinical Oncology. 19(1). 78–81. 4 indexed citations
9.
Collecchi, Paola, Piergiorgio Giannessi, Editta Baldini, et al.. (1996). Effects of Primary Chemotherapy on Biological Parameters of Locally Advanced Breast Cancera. Annals of the New York Academy of Sciences. 784(1). 419–426. 5 indexed citations
10.
Gardin, G., Angela Alama, R. Rosso, et al.. (1994). Relationship of variations in tumor cell kinetics induced by primary chemotherapy to tumor regression and prognosis in locally advanced breast cancer. Breast Cancer Research and Treatment. 32(3). 311–318. 31 indexed citations
11.
Baldini, Editta, G. Gardin, P. Pronzato, et al.. (1993). Stimulation of Human Breast Cancer in Vivo. Annals of the New York Academy of Sciences. 698(1). 418–422. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026